Tertiary lymphoid structures: new immunotherapy biomarker

作者：Fangyuan Yang, Jiahe Yang, Meijuan Wu, Cheng Chen, Xiaoyuan Chu · 发表于：Frontiers in Immunology · 年份：2024 · DOI：10.3389/fimmu.2024.1394505 · 被引用次数：24 · 研究领域：Cancer Immunotherapy and Biomarkers、Immune Cell Function and Interaction、Immunotherapy and Immune Responses

Immunotherapy shows substantial advancement in cancer and is becoming widely used in clinical practice. A variety of biomarkers have been proposed to predict the efficacy of immunotherapy, but most of them have low predictive ability. Tertiary lymphoid structures (TLSs), the aggregation of multiple lymphocytes, have been found to exist in various tumor tissues. TLSs have been shown to correlate with patient prognosis and immunotherapy response. This review summarizes the characteristics of TLSs and the inducing factors of TLS formation, presents available evidence on the role of TLSs in predicting immunotherapy response in different cancers, and lastly emphasizes their predictive potential for neoadjuvant immunotherapy efficacy.